GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. (Q44077198)

29 November 2017

title

GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. (English)

1 reference

29 November 2017

3

1 reference

29 November 2017

1

Ayhan Bozkurt

1 reference

29 November 2017

4

Per M Hellström

1 reference

29 November 2017

Erik Näslund

2

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

107

1 reference

29 November 2017

issue

1-3

1 reference

29 November 2017

page(s)

129-135

1 reference

The glucagon-like peptides

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

1 reference

7 January 2021

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Structure, measurement, and secretion of human glucagon-like peptide-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Characteristics of fasting and fed myoelectric activity in rat small intestine: evaluation by computer analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Cloning and functional expression of a human glucagon-like peptide-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900095-2

7 January 2021

10.1016/S0167-0115(02)00095-2

Identifiers

DOI

1 reference

29 November 2017

1 reference